Teva Pharmaceutical Industries Ltd
TEVA- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000818686
In the last 90 days, Teva Pharmaceutical Industries Ltd insiders filed 0 open-market purchases and 7 sales; 678 institutions reported holding it in 13F filings for Q2 2026, worth $24.7B in total; 3 superinvestors hold it, including Greenlight Capital and Duquesne Family Office.
Key figures
- Market capADS ratio not in SEC data
- –
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $18.7M in total
- 7
- 13F holdersQ2 2026, +28 vs. previous quarter
- 678
- 13F valueReported value at the end of Q2 2026
- $24.7B
- Superinvestors holdingAt the end of Q2 2026
- 3
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $17.3B
- +4.3% year over year
- Net income, FY2025
- $1.41B
- No comparable prior period
- Free cash flow, FY2025
- $1.15B
- +53.3% year over year
- Revenue, Q3 FY2026
- $4.39B
- −1.9% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 15, 2026.
- Short interest
- 28.1M
- Shares sold short
- Change
- −1.78M
- −6.0% vs. previous
- Days to cover
- 3.92
- At average daily volume
Superinvestors holding TEVA, Q2 2026
Go to the superinvestors tab3 superinvestors report holding Teva Pharmaceutical Industries Ltd on Form 13F. Percentages are the stock's share of each portfolio.
Greenlight Capital
David Einhorn
2.5%
Teva Pharmaceutical Industries Ltd's share of the portfolio
- Shares
- 2,886,059
- Value
- $97.8M
Duquesne Family Office
Stanley Druckenmiller
0.5%
Teva Pharmaceutical Industries Ltd's share of the portfolio
- Shares
- 624,999
- Value
- $21.2M
| Superinvestor | Weight | Value |
|---|---|---|
| ARK Invest | <0.1% | $2.33M |
Latest insider trades
See all insider tradesOpen-market purchases and sales by Teva Pharmaceutical Industries Ltd insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 6, 2026 (view filing)4:03 PM ET | Nov 5 | 1 day | Sabag MarkSee "Remarks" | SSale | −46.0K | $41.93 | −$1.93M | −36.3%80.8K after | |
| Nov 6, 2026 (view filing)4:01 PM ET | Nov 4 | 2 days | Bergwerk DovInterim Cheif Legal Officer | SSale | −26.3K | $41.72 | −$1.10M | −68.7%11.9K after | 2 lots |
| Sep 22, 2026 (view filing)5:01 PM ET | Sep 18 | 4 days | Savage BrianInterim Chief Legal Officer | SSale | −7.34K | $38.85 | −$285.2K | −46.3%8.50K after | 3 lots |
| Sep 22, 2026 (view filing)4:21 PM ET | Sep 18 | 4 days | Mignone RobertoDirector | SSale | −367.6K | $39.06 | −$14.4M | −100.0%0 after | |
| Aug 25, 2026 (view filing)4:05 PM ET | Aug 21 | 4 days | Weiss AmirChief Accounting Officer | SSale | −9.45K | $37.62 | −$355.3K | −41.9%13.1K after | 2 lots |
| Aug 25, 2026 (view filing)4:03 PM ET | Aug 21 | 4 days | Satchi-Fainaro RonitDirector | SSale | −415 | $37.25 | −$15.5K | −0.4%112.0K after | |
| Aug 19, 2026 (view filing)4:00 PM ET | Aug 17 | 2 days | Lippman EvanEVP, Business Development | SSale | −18.6K | $36.57 | −$680.3K | −42.1%25.6K after | 10b5-1 |
| Aug 10, 2026 (view filing)6:07 AM ET | Aug 5 | 5 daysLate | Zaks Tal ZviDirector | SSale | −17 | $34.87 | −$592.71 | 0.0%73.2K after | |
| Aug 5, 2026 (view filing)4:04 PM ET | Aug 3 | 2 days | Jover PlacidSee "Remarks" | SSale | −12.8K | $34.88 | −$447.4K | −65.4%6.77K after | 10b5-1 |
| Aug 5, 2026 (view filing)4:02 PM ET | Aug 3 | 2 days | Hughes Eric ASee "Remarks" | SSale | −25.6K | $34.88 | −$892.1K | −15.9%134.9K after | 10b5-1 |
Top 10 13F holders, Q2 2026
See all 678 holdersThe largest institutional positions in Teva Pharmaceutical Industries Ltd at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 63,894,301 | $2.16B | 0.03% | −1,242,163−1.9% | Reduced |
| Harel Insurance Investments & Financial Services Ltd. | 48,138,805 | $1.63B | 7.93% | +2,182,091+4.7% | Added |
| Phoenix Holdings Ltd. | 42,933,367 | $1.45B | 9.94% | +155,953+0.4% | Added |
| WCM Investment Management, LLC | 41,315,232 | $1.38B | 2.49% | +494,632+1.2% | Added |
| Clal Insurance Enterprises Holdings Ltd | 40,596,506 | $1.37B | 6.15% | +2,150,000+5.6% | Added |
| Menora Mivtachim Holdings Ltd. | 39,854,383 | $1.35B | 5.27% | +228,000+0.6% | Added |
| Migdal Insurance & Financial Holdings Ltd. | 38,922,212 | $1.32B | 8.44% | +1,020,000+2.7% | Added |
| Norges Bank | 32,299,753 | $1.09B | 0.11% | +32,299,753 | New |
| FMR LLC | 30,258,016 | $1.03B | 0.04% | −2,874,779−8.7% | Reduced |
| Exor Capital LLP | 20,205,943 | $684.6M | 14.73% | −7,564,914−27.2% | Reduced |
Holders of 5% or more of TEVA
See all 4 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Teva Pharmaceutical Industries Ltd.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Harel Insurance Investments & Financial Services Ltd. | 13G/A | 6.00%70.4M shares | −0.30 ppfrom 6.30% | Oct 6, 20253 filings | Nov 2, 2026 | SEC |
| Migdal Insurance & Financial Holdings Ltd. | 13G | 5.37%61.7M shares | New | Feb 17, 20261 filing | Feb 17, 2026 | SEC |
| Menora Mivtachim Holdings Ltd. | 13G | 5.00%57.4M shares | New | Jul 17, 20251 filing | Jul 17, 2025 | SEC |
| Phoenix Holdings Ltd. | 13G | 5.00%57.4M shares | – | Feb 1, 20243 filings | Jul 22, 2025 | SEC |
Politician trades
All politician trades in TEVA3 members of Congress reported 3 trades in Teva Pharmaceutical Industries Ltd since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Jul 21, 2026 |  Alan Armstrong Senate · OK | Buy | $1K-$15K |
| Dec 2, 2020 |  Greg Gianforte House · MT | Buy | $15K-$50K |
| May 15, 2020 |  Donna E. Shalala House · FL | Sell | $1K-$15K |
Senate · OK · Jul 21, 2026
Buy$1K-$15K
House · MT · Dec 2, 2020
Buy$15K-$50K
House · FL · May 15, 2020
Sell$1K-$15K